Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0000905148-25-003320

Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gagnon Robert E. Chief Financial Officer 2025-09-10 Grant or award +200,000 200,000 D
Derivatives
Gagnon Robert E. Chief Financial Officer 2025-09-02 Grant or award · Employee Stock Option (right to buy) +250,000 250,000 D
Loading xslF345X05/form4.xml…